NCT06351995: Neostigmine and Glycopyrrolate by Iontophoresis
- State
- Under way
- Phase
- Phase 3
- People
- 6 taking part
- Started
- 6 Nov 2020
- Primary completion
- 25 Oct 2022
- Arms
- Primary
- Results
- None posted
- 6 Nov 2020: Trial started
- 8 Apr 2024: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.